Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 54,300 shares, a decrease of 55.7% from the August 31st total of 122,600 shares. Approximately 0.3% of the shares of the stock are short sold. Based […]
University of Maryland Medical Center performs second pig-to-human heart transplant capitalgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalgazette.com Daily Mail and Mail on Sunday newspapers.
Medicenna Therapeutics (TSE:MDNA) Trading 7.8% Higher theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Medicenna Therapeutics (NASDAQ:MDNA – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $2.50 price target on the stock. HC Wainwright also issued estimates for Medicenna Therapeutics’ Q2 2024 earnings at ($0.05) EPS, Q3 2024 earnings at […]